OUT:JSEOUTsurance Group Limited Analysis
Data as of 2026-05-21 - not real-time
ZAC 7,034.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
OUTsurance Group trades at ZAc 7,034, sitting below its 20‑day (ZAc 7,099), 50‑day (ZAc 7,139) and 200‑day (ZAc 7,252) moving averages, signaling a short‑term bearish bias. The MACD is in a bearish configuration (histogram ‑3.25) and the RSI at 46 indicates neutral momentum, while volume has been trending downwards. Volatility is elevated at 22.6% over the past 30 days, yet the beta of 0.15 suggests the stock moves little relative to the broader market. On the valuation side, the price‑to‑earnings multiple of 21.8 is well above the industry average of 16.7 and the discounted cash‑flow model caps fair value near ZAc 5,217, implying the market is pricing a sizable premium. Fundamentals remain strong: revenue grew 13.6% YoY, ROE is an impressive 37%, free cash flow exceeds ZAc 3.2 bn and the balance sheet holds ZAc 9.5 bn in cash against modest debt. The dividend yield of 3.43% with a 73.8% payout is supported by robust cash generation. Analyst consensus of six forecasters rates the stock as a “buy” with a median target of ZAc 8,823, indicating roughly 21% upside. Recent material news notes the company’s successful rebrand and listing on the JSE, which has heightened investor visibility and contributed to the current “extreme greed” sentiment (fear‑greed index 91.2).
Given the divergence between strong fundamentals and bearish technical signals, the near‑term outlook is cautious, but the medium‑ to long‑term narrative remains positive as growth, cash strength and dividend appeal outweigh the valuation premium. Investors should weigh the short‑term price weakness against the upside potential embedded in analyst targets and the company’s solid earnings trajectory.
Given the divergence between strong fundamentals and bearish technical signals, the near‑term outlook is cautious, but the medium‑ to long‑term narrative remains positive as growth, cash strength and dividend appeal outweigh the valuation premium. Investors should weigh the short‑term price weakness against the upside potential embedded in analyst targets and the company’s solid earnings trajectory.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages and bearish MACD
- Decreasing trading volume
- Proximity to technical support at ZAc 6,905
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 13.6% revenue growth and 37% ROE
- Strong cash position with low net debt
- Analyst target price implying ~21% upside
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable 3.43% dividend yield
- Robust balance sheet and free cash flow generation
- Valuation premium relative to DCF and industry peers
Key Metrics & Analysis
Financial Health
Revenue Growth13.60%
Profit Margin11.90%
P/E Ratio21.8
ROE37.10%
ROA13.71%
Debt/Equity3.30
P/B Ratio8.0
Op. Cash FlowZAC6.6B
Free Cash FlowZAC3.2B
Industry P/E16.7
Technical Analysis
TrendBearish
RSI46.1
SupportZAC 6,905.00
ResistanceZAC 7,399.00
MA 20ZAC 7,099.15
MA 50ZAC 7,138.60
MA 200ZAC 7,251.59
MACDBearish
VolumeDecreasing
Fear & Greed Index91.18
Valuation
Fair ValueZAC 5,216.68
Target PriceZAC 8,555.50
Upside/Downside21.63%
GradeOvervalued
TypeGrowth
Dividend Yield3.43%
Risk Assessment
Beta0.15
Volatility22.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.